Asia Pacific Pharmaceutical Contract Sales Organizations Market Forecast to 2030
Asia Pacific Pharmaceutical Contract Sales Organizations Market Forecast to 2030 – Regional Analysis – by Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), and End User (Biopharmaceutical Companies and Pharmaceutical Companies)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Use of Telemedicine and Remote Detailing Drives Asia Pacific Pharmaceutical Contract Sales Organizations Market
The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organization (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates a fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry’s proactive approach to navigating the market’s complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.
Asia Pacific Pharmaceutical Contract Sales Organizations Market Overview
The Asia Pacific pharmaceutical contract sales organization market has experienced significant growth in recent years owing to the elevated demand for cost-effective sales and marketing solutions. Pharmaceutical companies face the challenge of reaching diverse and remote markets in countries such as China, India, and Japan, despite a significant demand for healthcare products in these countries. By outsourcing sales and marketing functions to CSOs, the companies can benefit from the expertise of specialized teams without the need for extensive infrastructure and personnel investments. Furthermore, the rise in chronic diseases and the growing aging population in the Asia Pacific region have also contributed to the expansion of the pharmaceutical contract sales organization market.
The increasing availability and adoption of digital technologies, and easy access to a large number of data sources allow pharmaceutical CSOs to gather and analyze real-time data, thereby assisting their clients with the use of actionable insights. In April 2023, SANOFI China adopted a scalable, commercial omnipresence CRM solution that would adapt to its evolving, dynamic business model, thereby accelerating digital transformation and allowing the company to continue working toward innovation. Omnipresence CRM uses advanced analytics, data sources, and machine learning to generate insights, support better decision-making, and create new opportunities for commercial teams to speed up results with increased agility.
Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
The Asia Pacific pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.
Based on services, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on modules, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on therapeutic area, the Asia Pacific pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on end user, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Based on country, the Asia Pacific pharmaceutical contract sales organizations market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific pharmaceutical contract sales organizations market in 2022.
Aenova Holding GmbH, CMIC Holdings Co Ltd, EPS Holdings Inc, IQVIA Holdings Inc, Mednext Pharmaceuticals Pvt Ltd, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Asia Pacific pharmaceutical contract sales organizations market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Asia Pacific pharmaceutical contract sales organizations market was valued at US$ 1,707.48 million in 2022 and is expected to reach US$ 3,646.88 million by 2030, registering a CAGR of 10.0% from 2022 to 2030. Increasing integration of digital technologies and growing interest of pharmaceutical companies to increase sales of products are among the critical factors attributed to the Asia Pacific pharmaceutical contract sales organizations market expansion.
In recent years, pharmaceutical companies are increasingly adopting innovative strategies to augment the sales of their products. One notable trend within this landscape is the heightened reliance on pharmaceutical contract sales organizations (CSOs) as a pivotal component of their commercialization endeavors. This underscores a proactive approach by pharmaceutical entities to navigate the complexities of the market. By engaging CSOs, these companies can tap into specialized sales forces, capitalizing on external proficiency to enhance market penetration and optimize sales performance. This collaborative paradigm enables pharmaceutical firms to streamline their operations and concentrate on core competencies such as research and development while concurrently leveraging the tailored expertise of CSOs to bolster their products’ market presence. The growing synergy between pharmaceutical companies and CSOs reflects a nuanced understanding of resource optimization, illustrating a commitment to adaptability and a keen awareness of the evolving dynamics within the fiercely competitive pharmaceutical landscape. This symbiotic relationship facilitates revenue maximization and positions pharmaceutical enterprises strategically in an environment where agility and targeted market strategies are paramount for sustained success.
On the contrary, quality issues associated with outsourcing hamper the Asia Pacific pharmaceutical contract sales organizations market.
Based on services, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held 72.2% share of Asia Pacific pharmaceutical contract sales organizations market in 2022, amassing US$ 1,231.99 million. It is projected to garner US$ 2,762.62 million by 2030 to expand at 10.6% CAGR during 2022-2030.
Based on modules, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held 51.6% share of Asia Pacific pharmaceutical contract sales organizations market in 2022, amassing US$ 881.07 million. It is projected to garner US$ 1,959.46 million by 2030 to expand at 10.5% CAGR during 2022-2030.
Based on therapeutic area, the Asia Pacific pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held 35.4% share of Asia Pacific pharmaceutical contract sales organizations market in 2022, amassing US$ 603.79 million. It is projected to garner US$ 1,349.32 million by 2030 to expand at 10.6% CAGR during 2022-2030.
Based on end user, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held 59.3% share of Asia Pacific pharmaceutical contract sales organizations market in 2022, amassing US$ 1,011.75 million. It is projected to garner US$ 2,106.97 million by 2030 to expand at 9.6% CAGR during 2022-2030.
Based on country, the Asia Pacific pharmaceutical contract sales organizations market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 25.2% share of Asia Pacific pharmaceutical contract sales organizations market in 2022. It was assessed at US$ 429.69 million in 2022 and is likely to hit US$ 1,041.45 million by 2030, exhibiting a CAGR of 11.7% during 2022-2030.
Key players operating in the Asia Pacific pharmaceutical contract sales organizations market are Aenova Holding GmbH, CMIC Holdings Co Ltd, EPS Holdings Inc, IQVIA Holdings Inc, Mednext Pharmaceuticals Pvt Ltd, Pfizer Inc, and Syneos Health Inc, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
5. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market – Asia Pacific Market Analysis
6.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Services
7.1 Overview
7.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Modules
8.1 Overview
8.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Therapeutic Area
9.1 Overview
9.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
11. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Country Analysis
11.1 Asia Pacific
11.1.1.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1.2 China
11.1.1.2.1 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.2.3 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.2.4 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.2.5 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Japan
11.1.1.3.1 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3.3 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.3.4 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.3.5 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 India
11.1.1.4.1 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.4.3 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4.4 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.4.5 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Australia
11.1.1.5.1 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.2 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.5.3 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.5.4 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5.5 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 South Korea
11.1.1.6.1 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.2 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.6.3 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.6.4 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.6.5 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.7 Rest of Asia Pacific
11.1.1.7.1 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.7.2 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.7.3 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.7.4 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.7.5 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 CMIC Holdings Co Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 EPS Holdings Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 IQVIA Holdings Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Syneos Health Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mednext Pharmaceuticals Pvt Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Aenova Holding GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.7 Pfizer Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 18. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 27. Glossary of Terms, Asia Pacific Pharmaceutical Contract Sales Organizations Market
LIST OF FIGURES
Figure 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Asia Pacific – PEST Analysis
Figure 3. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 24. Asia Pacific Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
The List of Companies – Asia Pacific Pharmaceutical Contract Sales Organizations Market
1. Aenova Holding GmbH
2. CMIC Holdings Co Ltd
3. EPS Holdings Inc
4. IQVIA Holdings Inc
5. Mednext Pharmaceuticals Pvt Ltd
6. Pfizer Inc
7. Syneos Health Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.